Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Non-Proliferative Diabetic Retinopathy
Clinical Trial
NCT07235085Last updated: 12/4/2025
OCUL
OCULAR THERAPEUTIX, INC